/CHE
CHE Stock - Chemed Corporation
Healthcare|Medical - Care FacilitiesNYSE
$435.33+1.18%
+$5.09 (+1.18%) • Dec 19
73
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.33
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+26.3%upside
Target: $549.82
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CHE
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$430.98 – $439.68
TARGET (TP)$550.00
STOP LOSS$400.50
RISK/REWARD1:3.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.46
52W High$623.61
52W Low$408.42
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.26B | $2.13B | $2.14B | $2.08B |
| Gross Profit | $854.35M | $798.82M | $765.09M | $769.80M | $701.39M |
| Gross Margin | 35.1% | 35.3% | 35.8% | 36.0% | 33.7% |
| Operating Income | $366.49M | $340.57M | $343.50M | $343.04M | $389.68M |
| Net Income | $302.00M | $272.51M | $249.62M | $268.55M | $319.47M |
| Net Margin | 12.4% | 12.0% | 11.7% | 12.6% | 15.4% |
| EPS | $20.10 | $18.11 | $16.72 | $17.14 | $20.02 |
Company Overview
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
50%
Hold / Neutral
1
50%
Sell / Underperform
0%
Analyst Consensus🟡 Mixed
1 Bullish1 Neutral/Bearish
Price Targets
$525
Average Target
↑ 20.6% Upside
Now
$500
Low
$525
Average
$550
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| September 2nd 2025 | Jefferies | Upgrade | Buy | $550 |
| July 25th 2025 | Jefferies | Initiation | Hold | $500 |
Earnings History & Surprises
CHEBeat Rate
61%
Last 18 quarters
Avg Surprise
+1.1%
EPS vs Estimate
Beats / Misses
11/7
Last 12 quarters
Latest EPS
$5.27
Q4 2025
EPS Surprise History
Q1 24
+5.6%
$6.60vs$6.25
Q2 24
-5.1%
$5.20vs$5.48
Q3 24
-2.1%
$5.47vs$5.59
Q4 24
-2.1%
$5.64vs$5.76
Q1 25
+0.7%
$6.83vs$6.78
Q2 25
+1.4%
$5.63vs$5.55
Q3 25
-10.7%
$4.27vs$4.78
Q4 25
-2.2%
$5.27vs$5.39
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 25, 2026 | $7.02 | — | — | — |
Q4 2025 | Oct 28, 2025 | $5.39 | $5.27 | -2.2% | ✗ MISS |
Q3 2025 | Jul 29, 2025 | $4.78 | $4.27 | -10.7% | ✗ MISS |
Q2 2025 | Apr 23, 2025 | $5.55 | $5.63 | +1.4% | ✓ BEAT |
Q1 2025 | Feb 26, 2025 | $6.78 | $6.83 | +0.7% | ✓ BEAT |
Q4 2024 | Oct 29, 2024 | $5.76 | $5.64 | -2.1% | ✗ MISS |
Q3 2024 | Jul 24, 2024 | $5.59 | $5.47 | -2.1% | ✗ MISS |
Q2 2024 | Apr 24, 2024 | $5.48 | $5.20 | -5.1% | ✗ MISS |
Q1 2024 | Feb 27, 2024 | $6.25 | $6.60 | +5.6% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $4.90 | $5.32 | +8.6% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $5.09 | $4.71 | -7.5% | ✗ MISS |
Q2 2023 | Apr 26, 2023 | $4.92 | $4.82 | -2.0% | ✗ MISS |
Q1 2023 | Feb 23, 2023 | $5.32 | $5.39 | +1.3% | ✓ BEAT |
Q4 2022 | Oct 31, 2022 | $4.65 | $4.74 | +1.9% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $4.78 | $4.84 | +1.3% | ✓ BEAT |
Q2 2022 | Apr 26, 2022 | $4.47 | $4.79 | +7.2% | ✓ BEAT |
Q1 2022 | Feb 24, 2022 | $5.08 | $5.25 | +3.3% | ✓ BEAT |
Q4 2021 | Oct 28, 2021 | $4.49 | $5.06 | +12.7% | ✓ BEAT |
Q3 2021 | Jul 27, 2021 | $4.29 | $4.60 | +7.2% | ✓ BEAT |
Latest News
RBC Capital Maintains Outperform on Chemed, Lowers Price Target to $572
➖ NeutralBenzinga•Nov 10, 2025, 03:31 PM
Chemed Affirms FY2025 Adj EPS Guidance of $22.00-$22.30 vs $22.15 Est
➖ NeutralBenzinga•Oct 28, 2025, 08:18 PM
Chemed Q3 Adj. EPS $5.27 Misses $5.36 Estimate, Sales $624.900M Miss $626.034M Estimate
📉 NegativeBenzinga•Oct 28, 2025, 08:17 PM
B of A Securities Maintains Buy on Chemed, Lowers Price Target to $595
➖ NeutralBenzinga•Sep 10, 2025, 03:16 PM
Jefferies Upgrades Chemed to Buy, Raises Price Target to $550
📈 PositiveBenzinga•Sep 2, 2025, 10:06 AM
Frequently Asked Questions about CHE
What is CHE's current stock price?
Chemed Corporation (CHE) is currently trading at $435.33 per share. The stock has moved +1.18% today.
What is the analyst price target for CHE?
The average analyst price target for CHE is $550.00, based on 1 analyst.
What sector is Chemed Corporation in?
Chemed Corporation operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NYSE exchange.
What is CHE's market cap?
Chemed Corporation has a market capitalization of $6.36 billion, making it a mid-cap company.
Does CHE pay dividends?
No, Chemed Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATR
AptarGroup, Inc.
$121.39
Mkt Cap: $8.0B
BRKR
Bruker Corporation
$46.48
Mkt Cap: $7.1B
BTSG
BrightSpring Health Services, Inc. Common Stock
$37.49
Mkt Cap: $6.8B
DVA
DaVita Inc.
$115.20
Mkt Cap: $8.1B
HSIC
Henry Schein, Inc.
$77.35
Mkt Cap: $9.5B
MTSR
Metsera, Inc.
$70.50
Mkt Cap: $7.4B
NUVL
Nuvalent, Inc.
$103.80
Mkt Cap: $7.5B
OPCH
Option Care Health, Inc.
$32.51
Mkt Cap: $5.4B
STVN
Stevanato Group S.p.A.
$20.53
Mkt Cap: $5.6B
TFX
Teleflex Incorporated
$121.89
Mkt Cap: $5.4B
Explore stocks similar to CHE for comparison